| 000 | 01205 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250511213054.0 | ||
| 264 | 0 | _c19911226 | |
| 008 | 199112s 0 0 eng d | ||
| 022 | _a0114-5916 | ||
| 024 | 7 |
_a10.2165/00002018-199106050-00008 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSuissa, S | |
| 245 | 0 | 0 |
_aStatistical methods in pharmacoepidemiology. Principles in managing error. _h[electronic resource] |
| 260 |
_bDrug safety _c |
||
| 300 |
_a381-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xadverse effects |
| 650 | 0 | 4 | _aBiometry |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 | _aDrug-Related Side Effects and Adverse Reactions |
| 650 | 0 | 4 |
_aEndometrial Neoplasms _xchemically induced |
| 650 | 0 | 4 | _aEpidemiology |
| 650 | 0 | 4 |
_aEstrogen Replacement Therapy _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGastrointestinal Hemorrhage _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aRisk Factors |
| 773 | 0 |
_tDrug safety _gvol. 6 _gno. 5 _gp. 381-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2165/00002018-199106050-00008 _zAvailable from publisher's website |
| 999 |
_c1936952 _d1936952 |
||